Patented Patagonian botanical
LEPTI-P40™
A rare, patented strain of Leptocarpha rivularis cultivated for 15+ years on a family farm near the pristine Patagonian mountains of Southern Chile — now entering the global nutraceutical market through a limited set of licensed partnerships.
From ancestral Patagonia to modern science — now opening to the world in 2026.
LEPTI-P40™ is positioned as a controlled-access, research-forward botanical ingredient system. It is cultivated by a single grower using a patented strain that would take more than a decade to reproduce to comparable potency. The entire plant is harvested to support its bioactive profile — with ongoing research and new studies expected in Q2 2026.
Designed for brands seeking a rare ingredient that supports healthy metabolic function and glucose metabolism.*
Positioned to support a healthy inflammatory response and recovery — without disease claims.*
Crown Harvest Distribution is the sole global distribution and licensing partner for LEPTI-P40™. Commercial access is intentionally limited to protect supply integrity, documentation standards, and partner differentiation.
Why global brands are watching
A controlled-access botanical platform built for category leaders.
LEPTI-P40™ is not a commodity ingredient. It’s a rare, licensed botanical with a protected origin story, a single-source cultivation model, and a research-forward narrative designed to help premium brands launch something genuinely differentiated.
First global release in 2026
For the first time, LEPTI-P40™ is being introduced to the international nutraceutical market through a limited licensing model.
Patented strain + time advantage
Built on 15+ years of cultivation work that would take others years to reproduce to comparable potency.
Science-forward, dossier-ready
Designed for partners who need documentation, repeatable quality, and an ingredient story that holds up under scrutiny.
Heritage + stewardship
Rooted in ancestral culture. Protected by modern cultivation.
Leptocarpha rivularis carries cultural and ancestral heritage across Southern Chile. LEPTI-P40™ honors that origin while applying disciplined cultivation, whole-plant harvesting, and verification standards designed for premium global brands.
One grower, one region, one protected supply model — designed to remain rare and controlled.
A protected botanical identity refined over 15+ years of cultivation work and selection.
Harvesting the entire plant supports a broad-spectrum bioactive profile for wellness positioning.*
Global access is managed exclusively through Crown Harvest Distribution.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Rarity, protected
One grower. One patented strain. One global channel.
LEPTI-P40™ is cultivated on a family-owned farm near Patagonia in Southern Chile. The program is intentionally limited so partners can launch with true differentiation — not wide-market availability.
Licensing and distribution are managed exclusively through Crown Harvest Distribution.
Research-forward
Backed by science — with more coming in Q2 2026.
LEPTI-P40™ is supported by a growing body of research exploring wellness-oriented structure/function positioning. Cutting-edge work is ongoing, with additional studies expected in Q2 2026 — helping early partners lead the narrative as the category evolves.
Metabolic support*
Supports healthy metabolic function and glucose metabolism as part of a balanced lifestyle.*
Inflammation support*
Supports a healthy inflammatory response and recovery to help maintain performance and wellness.*
Partner documentation
Qualified brands may request COAs, dossiers, and commercialization discussion through Crown Harvest Distribution.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
From field to science
The LEPTI-P40™ ecosystem.
Commercial cultivation, stewardship, and science — captured across the program.
Licensing access
Exclusive by design — limited partnerships only.
LEPTI-P40™ is entering the market through a controlled licensing program for a very limited set of qualified brands. This protects rarity, quality expectations, and partner differentiation.
Who manages global distribution and licensing?
Crown Harvest Distribution is the sole global distribution and licensing partner for LEPTI-P40™. All inquiries route through them.
What can LEPTI-P40 be positioned for?
Structure/function positioning includes support for healthy metabolic function and glucose metabolism, and support for a healthy inflammatory response.*
Why is it considered rare?
LEPTI-P40™ is cultivated by a single grower from a patented strain refined over 15+ years, offered through limited licensing to protect exclusivity.
How do we request a dossier or commercial discussion?
Use Crown Harvest’s contact portal or email to request documentation and licensing information. Qualified partners may receive COAs and technical materials.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LEPTI-P40™ licensing — global access begins in 2026
LEPTI-P40™ is a rare, patented botanical platform entering the supplement industry through a controlled licensing model. Crown Harvest Distribution is the exclusive channel for supply agreements, documentation, and partnership discussions.
*These statements have not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease.
